University of St Andrews and Technocomm Limited
Lead Participant:
UNIVERSITY OF ST ANDREWS
Abstract
To synthesise and investigate biological functionality of novel anti-infective candidate compounds to validate Technocomm's proprietary drug discovery system and invest new therapeutic sub-classes.
Lead Participant | Project Cost | Grant Offer |
|---|---|---|
| UNIVERSITY OF ST ANDREWS | £168,634 | £ 112,985 |
Participant |
||
| KTN LTD | ||
| UNIVERSITY OF ST ANDREWS |
People |
ORCID iD |